{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:45:54Z","timestamp":1792532754289,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.4158\/ep15748.dscpt2","type":"journal-article","created":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T10:58:29Z","timestamp":1449572309000},"page":"1415-1426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":323,"title":["American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Androgen Excess And Pcos Society Disease State Clinical Review: Guide To The Best Practices In The Evaluation And Treatment Of Polycystic Ovary Syndrome - Part 2"],"prefix":"10.1016","volume":"21","author":[{"given":"Neil F.","family":"Goodman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhoda H.","family":"Cobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Futterweit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Glueck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Legro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Carmina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP15748.DSCPT2_bb0010","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.4158\/EP15748.DSCPT2_bb0015","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.4158\/EP15748.DSCPT2_bb0020","first-page":"2694","article-title":"A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome","volume":"83","author":"Legro","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0025","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1210\/jc.2003-031205","article-title":"Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome","volume":"89","author":"Diamanti-Kandarakis","year":"2004","journal-title":"J Clinl Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0030","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1210\/jc.2007-1549","article-title":"Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society","volume":"92","author":"Salley","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0035","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0040","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/16.9.1995","article-title":"Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome","volume":"16","author":"Norman","year":"2001","journal-title":"Hum Reprod"},{"key":"10.4158\/EP15748.DSCPT2_bb0045","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.fertnstert.2008.02.091","article-title":"The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance","volume":"89","author":"Bremer","year":"2008","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSCPT2_bb0050","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.metabol.2008.05.002","article-title":"Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation","volume":"57","author":"Asagami","year":"2008","journal-title":"Metabolism"},{"key":"10.4158\/EP15748.DSCPT2_bb0055","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0015-0282(03)01007-0","article-title":"Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome","volume":"80","author":"Wu","year":"2003","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSCPT2_bb0060","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/humrep\/det015","article-title":"The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study","volume":"28","author":"Homburg","year":"2013","journal-title":"Hum Reprod"},{"key":"10.4158\/EP15748.DSCPT2_bb0065","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.2174\/138161212803307590","article-title":"Insulin resistance and polycystic ovary syndrome through life","volume":"18","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.4158\/EP15748.DSCPT2_bb0070","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.fertnstert.2008.09.018","article-title":"Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"92","author":"Moran","year":"2009","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSCPT2_bb0075","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1210\/er.2002-0015","article-title":"Insulin-lowering agents in the management of polycystic ovary syndrome","volume":"24","author":"De Leo","year":"2003","journal-title":"Endocr Rev"},{"key":"10.4158\/EP15748.DSCPT2_bb0080","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0085","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.fertnstert.2009.01.114","article-title":"Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial","volume":"93","author":"Romualdi","year":"2010","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSCPT2_bb0090","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSCPT2_bb0095","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1185\/03007995.2012.681636","article-title":"A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome","volume":"28","author":"Du","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"10.4158\/EP15748.DSCPT2_bb0100","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2265.2010.03934.x","article-title":"When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?","volume":"74","author":"Franks","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP15748.DSCPT2_bb0105","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"New Engl J Med"},{"key":"10.4158\/EP15748.DSCPT2_bb0110","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"10.4158\/EP15748.DSCPT2_bb0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1067\/mpd.2001.109603","article-title":"Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome","volume":"138","author":"Lewy","year":"2001","journal-title":"J Pediatr"},{"key":"10.4158\/EP15748.DSCPT2_bb0120","first-page":"66","article-title":"Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease","volume":"86","author":"Arslanian","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.4158\/EP15748.DSCPT2_bb0130","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0135","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.4158\/EP15748.DSCPT2_bb0140","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI118126","article-title":"Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome","volume":"96","author":"Dunaif","year":"1995","journal-title":"J Clin Invest"},{"key":"10.4158\/EP15748.DSCPT2_bb0145","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0015-0282(03)00347-9","article-title":"The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study","volume":"79","author":"Korhonen","year":"2003","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSCPT2_bb0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0155","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.fertnstert.2011.03.001","article-title":"Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome","volume":"95","author":"Hart","year":"2011","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSCPT2_bb0160","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.fertnstert.2010.02.015","article-title":"Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes","volume":"94","author":"Wiltgen","year":"2010","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSCPT2_bb0165","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","article-title":"Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria","volume":"27","author":"Yildiz","year":"2012","journal-title":"Hum Reprod"},{"key":"10.4158\/EP15748.DSCPT2_bb0170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2265.2011.04015.x","article-title":"Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight","volume":"75","author":"Sidhwani","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP15748.DSCPT2_bb0175","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and metaanalysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSCPT2_bb0180","first-page":"CD008565","article-title":"Statins for women with polycystic ovary syndrome not actively trying to conceive","volume":"10","author":"Raval","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.4158\/EP15748.DSCPT2_bb0185","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome","volume":"88","author":"Christian","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0190","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0195","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1093\/humrep\/dem324","article-title":"Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome","volume":"22","author":"Luque-Ram\u00edrez","year":"2007","journal-title":"Hum Reprod"},{"key":"10.4158\/EP15748.DSCPT2_bb0200","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1210\/jc.2011-1609","article-title":"Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls","volume":"96","author":"Lass","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0205","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2265.2010.03907.x","article-title":"Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study","volume":"74","author":"Chang","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP15748.DSCPT2_bb0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-126-1-199701010-00005","article-title":"Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization","volume":"126","author":"Birdsall","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP15748.DSCPT2_bb0215","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP15748.DSCPT2_bb0220","first-page":"74","article-title":"Risk of cardiovascular events in patients with polycystic ovary syndrome","volume":"70","author":"Iftikhar","year":"2012","journal-title":"Neth J Med"},{"key":"10.4158\/EP15748.DSCPT2_bb0225","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0230","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.4158\/EP15748.DSCPT2_bb0235","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/humrep\/15.4.785","article-title":"Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome","volume":"15","author":"Cibula","year":"2000","journal-title":"Hum Reprod"},{"key":"10.4158\/EP15748.DSCPT2_bb0240","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jcem.87.5.8471","article-title":"Menstrual cycle irregularity and risk for future cardiovascular disease","volume":"87","author":"Solomon","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0245","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/GME.0b013e31802cc7ab","article-title":"Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease","volume":"14","author":"Krentz","year":"2007","journal-title":"Menopause"},{"key":"10.4158\/EP15748.DSCPT2_bb0250","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/cen.12068","article-title":"Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study","volume":"78","author":"Mani","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP15748.DSCPT2_bb0255","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2007-0425","volume":"93","author":"Shaw","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0260","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/1479164109336050","article-title":"Long-term effect of metformin on metabolic parameters in the polycystic ovary syndrome","volume":"6","author":"Cheang","year":"2009","journal-title":"Diab Vasc Dis Res"},{"key":"10.4158\/EP15748.DSCPT2_bb0265","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/dc06-0618","article-title":"Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome","volume":"30","author":"Meyer","year":"2007","journal-title":"Diabetes Care"},{"key":"10.4158\/EP15748.DSCPT2_bb0270","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/met.2005.3.259","article-title":"Polycystic ovarian syndrome and insulin resistance: implications for estrogen use in premenopausal and postmenopausal women","volume":"3","author":"Cobin","year":"2005","journal-title":"Metab Syndr Relat Disord"},{"key":"10.4158\/EP15748.DSCPT2_bb0275","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2010-2547","article-title":"Drospirenone\/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors","volume":"96","author":"Tfayli","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0280","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1503\/cmaj.120677","article-title":"Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis","volume":"185","author":"Bird","year":"2013","journal-title":"CMAJ"},{"key":"10.4158\/EP15748.DSCPT2_bb0285","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1210\/jc.2008-0369","article-title":"Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries","volume":"93","author":"Franks","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0290","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1365-2265.2011.03983.x","article-title":"Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters","volume":"74","author":"Joharatnam","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP15748.DSCPT2_bb0295","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","article-title":"Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS","volume":"75","author":"Kahsar-Miller","year":"2001","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSCPT2_bb0300","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1210\/jcem.87.5.8387","article-title":"Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome","volume":"87","author":"Legro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0305","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2337\/dc07-2190","article-title":"Metabolic phenotype in the brothers of women with polycystic ovary syndrome","volume":"31","author":"Sam","year":"2008","journal-title":"Diabetes Care"},{"key":"10.4158\/EP15748.DSCPT2_bb0310","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.metabol.2007.08.010","article-title":"Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome","volume":"57","author":"Sam","year":"2008","journal-title":"Metabolism"},{"key":"10.4158\/EP15748.DSCPT2_bb0315","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng.732","article-title":"Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"43","author":"Chen","year":"2011","journal-title":"Nat Genet"},{"key":"10.4158\/EP15748.DSCPT2_bb0320","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ng.2384","article-title":"Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome","volume":"44","author":"Shi","year":"2012","journal-title":"Nat Genet"},{"key":"10.4158\/EP15748.DSCPT2_bb0325","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/jmedgenet-2011-100427","article-title":"Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts","volume":"49","author":"Goodarzi","year":"2012","journal-title":"J Med Genet"},{"key":"10.4158\/EP15748.DSCPT2_bb0330","doi-asserted-by":"crossref","first-page":"E1342","DOI":"10.1210\/jc.2011-3478","article-title":"Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry","volume":"97","author":"Welt","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0335","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/humrep\/des042","article-title":"Evaluating the association between endometrial cancer and polycystic ovary syndrome","volume":"27","author":"Haoula","year":"2012","journal-title":"Hum Reprod"},{"key":"10.4158\/EP15748.DSCPT2_bb0340","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ygyno.2005.06.029","article-title":"Endometrial cancer in young, normal-weight women","volume":"99","author":"Schmeler","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.4158\/EP15748.DSCPT2_bb0345","first-page":"263","article-title":"The WHO collaborative study of neoplasia and steroid contraceptives","volume":"17","author":"Endometrial cancer and combined oral contraceptives","year":"1988","journal-title":"Int J Epidemiol"},{"key":"10.4158\/EP15748.DSCPT2_bb0350","first-page":"227","article-title":"Recency, duration, and progestin content of oral contraceptives in relation to the incidence of endometrial cancer (Washington, USA)","volume":"5","author":"Voigt","year":"1994","journal-title":"Cancer Causes Control"},{"key":"10.4158\/EP15748.DSCPT2_bb0355","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"5","author":"Tang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.4158\/EP15748.DSCPT2_bb0360","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1158\/1535-7163.MCT-13-0439","article-title":"Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy","volume":"12","author":"Iglesias","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.4158\/EP15748.DSCPT2_bb0365","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2013.10.026","article-title":"Metformin use and endometrial cancer survival","volume":"132","author":"Nevadunsky","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.4158\/EP15748.DSCPT2_bb0370","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ygyno.2013.10.028","article-title":"Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help?","volume":"132","author":"Shafiee","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.4158\/EP15748.DSCPT2_bb0375","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.fertnstert.2006.06.050","article-title":"Utility of screening for other causes of infertility in women with \u201cknown\u201d polycystic ovary syndrome","volume":"87","author":"McGovern","year":"2007","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSCPT2_bb0380","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.4158\/EP15748.DSCPT2_bb0385","first-page":"CD008189","article-title":"Preconception lifestyle advice for people with subfertility","volume":"4","author":"Anderson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.4158\/EP15748.DSCPT2_bb0390","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0015-0282(02)03241-7","article-title":"A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women","volume":"78","author":"Fisher","year":"2002","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSCPT2_bb0395","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/AOG.0b013e31824da35c","article-title":"Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome","volume":"119","author":"Diamond","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.4158\/EP15748.DSCPT2_bb0400","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.fertnstert.2006.03.014","article-title":"Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate","volume":"85","author":"Tulandi","year":"2006","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSCPT2_bb0405","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1210\/jc.2011-3061","article-title":"Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial","volume":"97","author":"Morin-Papunen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0410","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/humrep\/dem426","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"23","author":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2008","journal-title":"Hum Reprod"},{"key":"10.4158\/EP15748.DSCPT2_bb0415","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"89","author":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2008","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSCPT2_bb0420","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-M\u00fcllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0425","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","article-title":"Serum anti-M\u00fcllerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome","volume":"91","author":"Pigny","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSCPT2_bb0430","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/humrep\/der297","article-title":"Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries","volume":"26","author":"Dewailly","year":"2011","journal-title":"Hum Reprod"},{"key":"10.4158\/EP15748.DSCPT2_bb0435","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1210\/jc.2013-2193","article-title":"The predictive value of circulating anti-M\u00fcllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study","volume":"98","author":"Mahran","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20393666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20393666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:59:59Z","timestamp":1761515999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20393666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":86,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1530891X20393666"],"URL":"https:\/\/doi.org\/10.4158\/ep15748.dscpt2","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Androgen Excess And Pcos Society Disease State Clinical Review: Guide To The Best Practices In The Evaluation And Treatment Of Polycystic Ovary Syndrome - Part 2","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP15748.DSCPT2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}